Tarek Hamouda

Biolog (United States) — United States

Medicine · Health Sciences

20h-index2.1kcitations27works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(8), Immune Response and Inflammation(6), Immunotherapy and Immune Responses(6), Respiratory viral infections research(5), Pneumonia and Respiratory Infections(3)

Publications27 total

An intranasal adjuvanted, recombinant influenza A/H5 vaccine primes against diverse H5N1 clades: a phase I trial
Nature Communications·2025· 1 citedOpen Access
An intranasal adjuvanted, recombinant influenza A/H5 vaccine candidate induces broad priming against diverse influenza A/H5N1 virus clades in a phase I randomized trial in healthy adults
2025· 1 citedOpen Access
Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes
Vaccine·2019· 34 citedOpen Access
A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice
Vaccine·2017· 54 citedOpen Access
Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats
Human Vaccines & Immunotherapeutics·2015· 29 citedOpen Access
Formulation, High Throughput In Vitro Screening and In Vivo Functional Characterization of Nanoemulsion-Based Intranasal Vaccine Adjuvants
PLoS ONE·2015· 44 citedOpen Access
Intranasal immunization with W<sub>80</sub>5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model
Human Vaccines & Immunotherapeutics·2013· 13 citedOpen Access
Smart Home: Integrating Internet of Things with Web Services and Cloud Computing
2013· 266 cited
NanoBio™ Nanoemulsion for Mucosal Vaccine Delivery
2012· 1 cited
Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine
Vaccine·2012· 40 citedOpen Access
Community Policing 'Social Contract for Social Order'
SSRN Electronic Journal·2012Open Access
Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens
Vaccine·2011· 82 cited
A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced Disease
PLoS ONE·2011· 73 citedOpen Access
<i>In Vitro</i> Antibacterial Activity of NB-003 against Propionibacterium acnes
Antimicrobial Agents and Chemotherapy·2011· 39 citedOpen Access
Intranasal Immunization of Ferrets with Commercial Trivalent Influenza Vaccines Formulated in a Nanoemulsion-Based Adjuvant
Clinical and Vaccine Immunology·2011· 52 citedOpen Access
Efficacy, immunogenicity and stability of a novel intranasal Nanoemulsion-adjuvanted influenza vaccine in a murine model
Human Vaccines·2010· 41 cited
Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury
Surgery·2010· 85 cited
NB-002, a Novel Nanoemulsion with Broad Antifungal Activity against Dermatophytes, Other Filamentous Fungi, and <i>Candida albicans</i>
Antimicrobial Agents and Chemotherapy·2009· 48 citedOpen Access
NB-002, a Novel Nanoemulsion with Anti-Dermatophyte Activity
46th Annual Meeting·2008· 2 cited
A Novel Nanoemulsion Adjuvant Enhancing the Immune Response to β-propiolactone Inactivated Influenza Virus Using a Nasal Route in a Ferret Model
46th Annual Meeting·2008
page 1 of 2Next →

Frequent Co-authors

James R. Baker(16), Andrzej Myc(9), Ali Fattom(7), Susan Ciotti(5), Jeffrey J. Landers(4), Joyce A. Sutcliffe(4), Jessie Pannu(4), Zhengyi Cao(3), Nicholas W. Lukacs(3), Douglas M. Smith(3), Paul E. Makidon(3), Jessica J. O’Konek(3), Vira Bitko(3), Amy Y. Shih(2), Piotr P. Myc(2), Anna U. Bielinska(2), Katarzyna Janczak(2), Jakub K. Simon(2), Alec McCarthy(2), Amparo Valentín Martín(2)